WithdrawnNCT03061136
Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia
This study was withdrawn before enrollment.
In Palo AltoSchizophreniaMedication studyAges 18–55
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT00018629
Cognitive - Behavioral Therapy
Official study title
Rehabilitation of Older Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In San DiegoSchizophreniaInterventional studyAges 45+
TerminatedNCT00211302
Cognitive Improvement With Aripiprazole (Abilify) in people with Schizophrenia (BMS)
Official study title
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia. (BMS)
This study ended early.
In ShreveportSchizophreniaMedication studyAges 18–65
TerminatedNCT00211380
Cognitive Improvement With Aripiprazole (Abilify) in people with Schizophrenia (SFBRI)
Official study title
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia, (SFBRI).
This study ended early.
In ShreveportSchizophreniaMedication studyAges 18–65
CompletedNCT01175642
Cognitive Remediation and Functional Skills Training in Schizophrenia
Official study title
Specificity and Generalizability of Cognitive Remediation and Functional Skills Training in Schizophrenia
This study has finished and is no longer accepting participants.
In KingstonSchizophreniaBehavioural studyAges 18–65
CompletedNCT01609153
Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
Official study title
A Randomized Double-blind Controlled Trial to Assess the Benefits of Olanzapine and Amisulpride Combination Treatment in Acutely Ill Schizophrenia Patients. - COMBINE
This study has finished and is no longer accepting participants.
Multiple locations, including AachenSchizophreniaMedication studyAges 18–65
CompletedNCT00237848
D-Serine for Enhancing Cognitive Retraining for Schizophrenia
Official study title
D-Serine Augmentation of Cognitive Retraining in Schizophrenia
This study has finished and is no longer accepting participants.
In BangaloreSchizophreniaMedication studyAges 18–65
CompletedNCT00237809
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including New HavenSchizophreniaMedication studyAges 18–65
TerminatedNCT01420575
Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia
Official study title
Using a Visual Decision Aid (DA) to Facilitate Shared Decision Making (SDM) During Antipsychotic Treatment in Schizophrenia.
This study ended early.
In OmahaSchizophreniaBehavioural studyAges 19–65
CompletedNCT00690235
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
Official study title
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Effects of Pramlintide on Weight Reduction in Clozapine- and Olanzapine-Induced Weight Gain in Obese People Diagnosed With Schizophrenia
This study has finished and is no longer accepting participants.
In DallasSchizophreniaMedication studyAges 18–65
CompletedNCT01969500
Development of a Mobile System for Self-management of Schizophrenia (SOS)
This study has finished and is no longer accepting participants.
In ManchesterSchizophreniaBehavioural studyAges 18+
CompletedNCT01242371
Study of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
Official study title
A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
In TowsonSchizophreniaPlacebo comparisonAges 18–65
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.